Byotrol develops landmark test for long-lasting antiviral efficacy
Shares in infection control and prevention specialist Byotrol (BYOT:AIM) surged 5% higher on Friday to 6.52p after the company announced a landmark test protocol for long-lasting antiviral efficacy.STANDING BY PRODUCT CLAIMSByotrol...
26 February 2021